These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 28912015)

  • 41. Clinical application of vascular regenerative therapy for peripheral artery disease.
    Suzuki H; Iso Y
    Biomed Res Int; 2013; 2013():179730. PubMed ID: 24350247
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy?
    Werner N; Nickenig G
    Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):257-66. PubMed ID: 16322535
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Autologous bone marrow-derived cell therapy in patients with critical limb ischemia: a meta-analysis of randomized controlled clinical trials.
    Teraa M; Sprengers RW; van der Graaf Y; Peters CE; Moll FL; Verhaar MC
    Ann Surg; 2013 Dec; 258(6):922-9. PubMed ID: 23426345
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A review of the pathophysiology and potential biomarkers for peripheral artery disease.
    Krishna SM; Moxon JV; Golledge J
    Int J Mol Sci; 2015 May; 16(5):11294-322. PubMed ID: 25993296
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endothelial progenitor cells: new perspectives and applications in cardiovascular therapies.
    Marsboom G; Janssens S
    Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):687-701. PubMed ID: 18510485
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Imaging stem cell therapy for the treatment of peripheral arterial disease.
    Ransohoff JD; Wu JC
    Curr Vasc Pharmacol; 2012 May; 10(3):361-73. PubMed ID: 22239638
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current therapies and investigational drugs for peripheral arterial disease.
    Suzuki J; Shimamura M; Suda H; Wakayama K; Kumagai H; Ikeda Y; Akazawa H; Isobe M; Komuro I; Morishita R
    Hypertens Res; 2016 Apr; 39(4):183-91. PubMed ID: 26631852
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gene therapy in peripheral artery disease.
    Sanada F; Taniyama Y; Kanbara Y; Otsu R; Ikeda-Iwabu Y; Carracedo M; Rakugi H; Morishita R
    Expert Opin Biol Ther; 2015 Mar; 15(3):381-90. PubMed ID: 25633211
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel stem cell source for vasculogenesis in ischemia: subfraction of side population cells from dental pulp.
    Iohara K; Zheng L; Wake H; Ito M; Nabekura J; Wakita H; Nakamura H; Into T; Matsushita K; Nakashima M
    Stem Cells; 2008 Sep; 26(9):2408-18. PubMed ID: 18583536
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Translational Relevance of Advanced Age and Atherosclerosis in Preclinical Trials of Biotherapies for Peripheral Artery Disease.
    Webster KA
    Genes (Basel); 2024 Jan; 15(1):. PubMed ID: 38275616
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapeutic strategies for cell-based neovascularization in critical limb ischemia.
    Samura M; Hosoyama T; Takeuchi Y; Ueno K; Morikage N; Hamano K
    J Transl Med; 2017 Feb; 15(1):49. PubMed ID: 28235425
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stem cell-based therapies to promote angiogenesis in ischemic cardiovascular disease.
    Hou L; Kim JJ; Woo YJ; Huang NF
    Am J Physiol Heart Circ Physiol; 2016 Feb; 310(4):H455-65. PubMed ID: 26683902
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumor necrosis factor-α-activated mesenchymal stem cells promote endothelial progenitor cell homing and angiogenesis.
    Kwon YW; Heo SC; Jeong GO; Yoon JW; Mo WM; Lee MJ; Jang IH; Kwon SM; Lee JS; Kim JH
    Biochim Biophys Acta; 2013 Dec; 1832(12):2136-44. PubMed ID: 23959047
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stem cells as a new treatment for peripheral artery disease: hype or hope? The point of view of a vascular surgeon.
    Lehalle B
    Biomed Mater Eng; 2015; 25(1 Suppl):73-8. PubMed ID: 25538058
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapeutic Angiogenesis Using Autologous CD34-Positive Cells for Vascular Diseases.
    Fujita Y; Kawamoto A
    Ann Vasc Dis; 2022 Dec; 15(4):241-252. PubMed ID: 36644256
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic angiogenesis of adipose-derived stem cells for ischemic diseases.
    Zhao L; Johnson T; Liu D
    Stem Cell Res Ther; 2017 Jun; 8(1):125. PubMed ID: 28583178
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The bone marrow--cardiac axis of myocardial regeneration.
    Liao R; Pfister O; Jain M; Mouquet F
    Prog Cardiovasc Dis; 2007; 50(1):18-30. PubMed ID: 17631435
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cell therapy and gene therapy using endothelial progenitor cells for vascular regeneration.
    Asahara T
    Handb Exp Pharmacol; 2007; (180):181-94. PubMed ID: 17554509
    [TBL] [Abstract][Full Text] [Related]  

  • 59. From bench to bedside: review of gene and cell-based therapies and the slow advancement into phase 3 clinical trials, with a focus on Aastrom's Ixmyelocel-T.
    Bartel RL; Booth E; Cramer C; Ledford K; Watling S; Zeigler F
    Stem Cell Rev Rep; 2013 Jun; 9(3):373-83. PubMed ID: 23456574
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is Regenerative Medicine Ready for Prime Time in Diabetic Polyneuropathy?
    Himeno T; Kamiya H; Nakamura J
    Curr Diab Rep; 2018 Jan; 18(1):3. PubMed ID: 29383511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.